Liang, L., Mai, S., Sethi, G., Luo, Y., Ma, Z., Wu, L., Lu, D., Han, J., Cai, R., Zhou, Y., Wang, X., Liu, L.

Background
Predicting neoadjuvant immunochemotherapy (NICT) response remains a critical challenge in esophageal squamous cell carcinoma (ESCC) management. While the gut bacteriome’s role in immunotherapy has been established, the mycobiome&rsquo…